XELODA

This brand name is authorized in Albania, Austria, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug XELODA contains one active pharmaceutical ingredient (API):

1 Capecitabine UNII 6804DJ8Z9U - CAPECITABINE

Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). There is evidence that the metabolism of 5-FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid, thereby interfering with the synthesis of deoxyribonucleic acid (DNA). The incorporation of 5-FU also leads to inhibition of RNA and protein synthesis. Read about Capecitabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Xeloda 150mg and 500mg Film-coated Tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC06	Capecitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	Identifier(s): 578/41
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529206703112315, 529206704119313
Country: CA	Health Products and Food Branch	Identifier(s): 02238453, 02238454
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00410399, 00410407, 01163661, 05385358, 05516079, 06568687, 06797672, 06849073, 10917538, 12367131, 15612513
Country: EE	Ravimiamet	Identifier(s): 1013308, 1013319
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00163002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 397752
Country: FR	Base de données publique des médicaments	Identifier(s): 65918903, 69771849
Country: HK	Department of Health Drug Office	Identifier(s): 46233, 46234
Country: IT	Agenzia del Farmaco	Identifier(s): 035219017, 035219029
Country: JP	医薬品医療機器総合機構	Identifier(s): 4223005F1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003995, 1003996
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 522M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 59358, 59366
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100103613, 100103620
Country: SG	Health Sciences Authority	Identifier(s): 10677P, 10678P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6993181H
Country: US	FDA, National Drug Code	Identifier(s): 0004-1100, 0004-1101
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/26/0198, 33/26/0199